SARCNU Uses, Dosage, Side Effects and more
SARCNU has been used in trials studying the treatment of Colorectal Cancer, Brain and Central Nervous System Tumors, and Unspecified Adult Solid Tumor, Protocol Specific.
| Trade Name | SARCNU |
| Generic | 2-chloroethyl-3-sarcosinamide-1-nitrosourea |
| 2-chloroethyl-3-sarcosinamide-1-nitrosourea Other Names | SARCNU, Sarmustine |
| Type | |
| Formula | C6H11ClN4O3 |
| Weight | Average: 222.63 Monoisotopic: 222.0519679 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
